top of page
1 July 2024
Re: “Sublingual Estradiol Offers No Apparent Advantage over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study” by Yaish et al.
Access this peer-reviewed publication here:
bottom of page